Associated Papers
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 2007
Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
Dimitrova A et al.
The Pharmacogenomics Journal, 2005
Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.
Nakayama J et al.
Neurology, 2004
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G et al.
Molecular Psychiatry, 2004
Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.
Yoshikawa T et al.
Molecular Psychiatry, 2001
Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).
Yoshikawa T et al.
Molecular Psychiatry, 2000
A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
Sjøholt G et al.
Molecular Psychiatry, 2000
Select a paper to view details